Multicenter phase II trial of interleukin-2, interferon-alpha, and 13-cis-retinoic acid in patients with metastatic renal-cell carcinoma. - Stadler,W.M.; Kuzel,T.; Dumas,M.; Vogelzang,N.J. (J Clin Oncol, 1998)